Revenue
0 USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Fundies. English
AIBOTICS, INC.
EDGARAnnual consolidated revenue for 2025: about USD 2.183K, using the latest reported figures. The previous period, 2024, was about USD 0.
Latest quarter
- Cash and cash equivalents
- 438 thousand USD Source
Exact value
438425 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 723 million shares Source
Exact value
722506634 shares
Reported share-count change
1,299.53% · 671 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
0 USD
2025-07-01 – 2026-06-30
Net income
-2.09 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
-349 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -371636 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -192918 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -458240 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -371636 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -36258 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -83280 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -36258 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-16.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 4 of 11 periods available· newest 2025-12-31
- Operating income: 8 of 11 periods available· newest 2025-12-31
- Net income: 6 of 11 periods available· newest 2025-12-31
- Operating cash flow: 8 of 11 periods available· newest 2025-12-31
- Capital expenditure: 3 of 11 periods available· newest 2022-12-31
- Total assets: 4 of 11 periods available· newest 2025-12-31
- Total liabilities: 4 of 11 periods available· newest 2025-12-31
- Current assets: 4 of 11 periods available· newest 2025-12-31
- Current liabilities: 4 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 2 of 11 periods available· newest 2019-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 4 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+USD 2,183Prior period
USD 0
–
Current period
USD 2,183
–
Exact inputs and evidence
2183 − 0 = 2183 USD
0 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source2183 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 367,476Prior period
−USD 1.85 million
–
Current period
−USD 2.22 million
–
Exact inputs and evidence
-2215751 − -1848275 = -367476 USD
-1848275 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-2215751 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 199,203Prior period
−USD 259,037
–
Current period
−USD 458,240
–
Exact inputs and evidence
-458240 − -259037 = -199203 USD
-259037 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-458240 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 2,183 100% of revenue
- Cost of revenue USD 0 0% of revenue
- Operating expenses USD 1.85 million 84,602% of revenue
- Operating income −USD 1.84 million −84,502% of revenue
- Tax, interest and other Derived USD 371,078 16,999% of revenue
- Net income −USD 2.22 million −101,500% of revenue
Cash
- Operating cash flow −USD 458,240 −20,991% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2018 Not shown: operating income or net income is not reported.
- 2019 Not shown: operating income or net income is not reported.
- 2024 Not shown: operating income or net income is not reported.
- 2025 Operating loss: operating costs were 84,602% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | 0 | 186074 Derived | -186074 | Unavailable | Unavailable | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 0 | 251718 Derived | -251718 | Unavailable | Unavailable | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 0 | 1634817 Derived | -1634817 | 213458 Derived | -1848275 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 2183 | 1846856 Derived | -1844673 | 371078 Derived | -2215751 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 2.2K 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Revenue | 0 |
|
| 2019 | Revenue | 0 |
|
| 2024 | Revenue | 0 |
|
| 2025 | Revenue | 2183 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | No prior comparable period |
|
| 2024 | Year over year | No prior comparable period |
|
| 2025 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -84,501.7% 2025
Net margin -101,500.3% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Operating margin | Not reported |
|
| 2019 | Operating margin | Not reported |
|
| 2024 | Operating margin | Not reported |
|
| 2025 | Operating margin | -84,501.7% |
|
| 2018-12-31 | Net margin | Not reported |
|
| 2019-12-31 | Net margin | Not reported |
|
| 2024 | Net margin | Not reported |
|
| 2025 | Net margin | -101,500.3% |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -458.2K 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Operating cash flow | -68534 |
|
| 2019 | Operating cash flow | 98667 |
|
| 2024 | Operating cash flow | -259037 |
|
| 2025 | Operating cash flow | -458240 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
552.8% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Liabilities / assets | 56.9% |
|
| 2019 | Liabilities / assets | 46.4% |
|
| 2024 | Liabilities / assets | 333% |
|
| 2025 | Liabilities / assets | 552.8% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.06× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Current assets / current liabilities | 1.76× |
|
| 2019 | Current assets / current liabilities | 2.16× |
|
| 2024 | Current assets / current liabilities | 0.04× |
|
| 2025 | Current assets / current liabilities | 0.06× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | Unavailable Not reported for this period. | −USD 68,534 Exact valueExact value: -68534 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | Unavailable Not reported for this period. | USD 98,667 Exact valueExact value: 98667 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 16,029 Exact valueExact value: -16029 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14,253 Exact valueExact value: -14253 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14,253 Calculation and evidence-14253 − 0 USD Exact free cash flow: -14253 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 5.14 million Exact valueExact value: -5138591 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 235,482 Exact valueExact value: -235482 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2,746 Exact valueExact value: 2746 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 238,228 Calculation and evidence-235482 − 2746 USD Exact free cash flow: -238228 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 2.61 million Exact valueExact value: -2611869 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 656,620 Exact valueExact value: -656620 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 656,620 Calculation and evidence-656620 − 0 USD Exact free cash flow: -656620 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 1.18 million Exact valueExact value: -1181347 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 106,765 Exact valueExact value: -106765 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 1.85 million Exact valueExact value: -1848275 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 259,037 Exact valueExact value: -259037 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 2.22 million Exact valueExact value: -2215751 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 458,240 Exact valueExact value: -458240 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
36 filings · 1,591 latest values · 1,591 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001763329, 1763329, AIBT, edgar:1763329
Also known as 20/20 GLOBAL, INC, 20/20 GLOBAL, INC., 20/20 Global, Inc., AIBOTICS, INC., AIBotics, Inc., MYCOTOPIA THERAPIES, INC., Mycotopia Therapies, Inc.